Intervertebral Disc Disease
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
SeikagakuCondoliase
SeikagakuCondoliase
OrganogenesisNuCel with Autograft
Clinical Trials (3)
Total enrollment: 1,453 patients across 3 trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Start: Mar 2015Est. completion: Feb 20181,011 patients
Phase 3Completed
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Start: Sep 2013Est. completion: Aug 2017385 patients
Phase 3Completed
Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine
Start: Dec 2013Est. completion: Aug 201957 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.